Evidence map›Paper›PMID 24845081›Full record

ArticlePLoS medicine2014

Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study.

Claudia Langenberg, Stephen J Sharp, Paul W Franks, Robert A Scott, Panos Deloukas, Nita G Forouhi, Philippe Froguel, Leif C Groop, Torben Hansen, Luigi Palla and 37 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 7 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 7 syntheses or guidelines pooled it, 232 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Gene-lifestyle interaction on risk of type 2 diabetes: A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2019
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Association of genetic risk and physical activity with incident type 2 diabetes.The Journal of clinical endocrinology and metabolism · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 11 countries.

Claudia LangenbergMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Stephen J SharpMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Paul W FranksLund University, Malmö, Sweden; Umeå University, Umeå, Sweden.
Robert A ScottMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Panos DeloukasThe Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Nita G ForouhiMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Philippe FroguelImperial College London, London, United Kingdom.
Leif C GroopUniversity Hospital Scania, Malmö, Sweden; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Torben HansenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Luigi PallaMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Oluf PedersenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Science, University of Aarhus, Aarhus, Denmark; Institute of Biomedical Science, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Matthias B SchulzeGerman Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
Maria-Jose TormoDepartment of Epidemiology, Murcia Regional Health Council, Murcia, Spain; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Department of Health and Social Sciences, Universidad de Murcia, Spain.
Eleanor WheelerThe Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Claudia AgnoliEpidemiology and Prevention Unit, Milan, Italy.
Larraitz ArriolaConsorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Public Health Division of Gipuzkoa, San Sebastian, Spain; Instituto de Investigación Sanitaria BioDonostia, Basque Government, San Sebastian, Spain.
Aurelio BarricarteConsorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Navarre Public Health Institute, Pamplona, Spain.
Heiner BoeingGerman Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
Geraldine M ClarkeWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Françoise Clavel-ChapelonInserm, CESP U1018, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France.
Eric J DuellCatalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.
Guy FagherazziInserm, CESP U1018, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France.
Rudolf KaaksGerman Cancer Research Center, Heidelberg, Germany.
Nicola D KerrisonMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Timothy J KeyUniversity of Oxford, Oxford, United Kingdom.
Kay Tee KhawUniversity of Cambridge, Cambridge, United Kingdom.
Janine KrögerGerman Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
Martin LajousInserm, CESP U1018, Villejuif, France; Center for Research on Population Health, National Institute of Public Health of Mexico, Cuernavaca, Mexico; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Andrew P MorrisWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Carmen NavarroDepartment of Epidemiology, Murcia Regional Health Council, Murcia, Spain; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Unit of Preventive Medicine and Public Health, School of Medicine, University of Murcia, Murcia, Spain.
Peter M NilssonLund University, Malmö, Sweden.
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark; Aalborg University Hospital, Aalborg, Denmark.
Domenico PalliCancer Research and Prevention Institute, Florence, Italy.
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Olov RolandssonUmeå University, Umeå, Sweden.
Carlotta SacerdoteUnit of Cancer Epidemiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, University of Turin, Turin, Italy; Piedmont Reference Center for Epidemiology and Cancer Prevention, Torino, Italy; Human Genetics Foundation, Torino, Italy.
María-José SánchezConsorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Andalusian School of Public Health, Granada, Spain.
Nadia SlimaniInternational Agency for Research on Cancer, Lyon, France.
Annemieke M W SpijkermanNational Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Rosario TuminoAzienda Sanitaria Provinciale di Ragusa, Ragusa, Italy; Aire Onlus, Ragusa, Italy.
Daphne L van der ANational Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Yvonne T van der SchouwUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Inês BarrosoThe Wellcome Trust Sanger Institute, Cambridge, United Kingdom; University of Cambridge Metabolic Research Laboratories, Cambridge, United Kingdom.
Mark I McCarthyWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Elio RiboliSchool of Public Health, Imperial College London, London, United Kingdom.
Nicholas J WarehamMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Medical Research Council · GBUniversity of Cambridge · GBGerman Institute of Human Nutrition · DEInstituto de Salud Carlos III · ESUniversity of Oxford · GBImperial College London · GBNational Institute for Public Health and the Environment · NLUmeå University · SEWellcome Sanger Institute · GBAalborg University Hospital · DKAgenzia Regionale Sanitaria della Puglia · ITAndalusian School of Public Health · ESCentre de recherche en Epidémiologie et Santé des Populations · FRCentre for Human Genetics · GBCentre International de Recherche sur le Cancer · FRFederico II University Hospital · ITGerman Cancer Research Center · DEGobierno del Principado de Asturias · ESInserm · FRInstitut Català d'Oncologia · ES

Funding

Cancer Research UK 14136Cancer Research UK 16491Medical Research Council G0401527Medical Research Council G0601261Medical Research Council G1000143Medical Research Council G1002084Medical Research Council MC_U106179471Medical Research Council MC_UP_A100_1003Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5Wellcome Trust 083270/Z/07/ZWellcome Trust 090532Wellcome Trust 098017World Health Organization 001
6 · The paper itself

Abstract

backgroundUnderstanding of the genetic basis of type 2 diabetes (T2D) has progressed rapidly, but the interactions between common genetic variants and lifestyle risk factors have not been systematically investigated in studies with adequate statistical power. Therefore, we aimed to quantify the combined effects of genetic and lifestyle factors on risk of T2D in order to inform strategies for prevention. METHODS AND

findingsThe InterAct study includes 12,403 incident T2D cases and a representative sub-cohort of 16,154 individuals from a cohort of 340,234 European participants with 3.99 million person-years of follow-up. We studied the combined effects of an additive genetic T2D risk score and modifiable and non-modifiable risk factors using Prentice-weighted Cox regression and random effects meta-analysis methods. The effect of the genetic score was significantly greater in younger individuals (p for interaction  = 1.20×10-4). Relative genetic risk (per standard deviation [4.4 risk alleles]) was also larger in participants who were leaner, both in terms of body mass index (p for interaction  = 1.50×10-3) and waist circumference (p for interaction  = 7.49×10-9). Examination of absolute risks by strata showed the importance of obesity for T2D risk. The 10-y cumulative incidence of T2D rose from 0.25% to 0.89% across extreme quartiles of the genetic score in normal weight individuals, compared to 4.22% to 7.99% in obese individuals. We detected no significant interactions between the genetic score and sex, diabetes family history, physical activity, or dietary habits assessed by a Mediterranean diet score.

conclusionsThe relative effect of a T2D genetic risk score is greater in younger and leaner participants. However, this sub-group is at low absolute risk and would not be a logical target for preventive interventions. The high absolute risk associated with obesity at any level of genetic risk highlights the importance of universal rather than targeted approaches to lifestyle intervention.

Indexed as

Genetic Predisposition to DiseaseLife StyleAllelesBody Mass IndexCohort StudiesDiabetes Mellitus, Type 2Diet, MediterraneanFemaleHumansMaleMiddle AgedMotor ActivityPolymorphism, Single NucleotideProportional Hazards ModelsRisk FactorsWaist Circumference

Identifiers

PMID24845081
PMCPMC4028183
OpenAlexW2155536385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.